Home › Funds › Carmignac Gestion › RPRX

Carmignac Gestion position in RPRX

ROYALTY PHARMA PLC · Health Care

Carmignac Gestion reported holding 683,200 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$39.9M, representing 0.63% of its reported portfolio and ranking #36 among its reported holdings. Carmignac Gestion has disclosed RPRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)683.20K sh
Reported value held$39.87M
Portfolio Weight0.63%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Carmignac Gestion's RPRX position evolved

Carmignac Gestion first disclosed a stake in RPRX in Q1 2026 at 631,200 shares (US$30.3M). The position peaked in Q3 2026 at 683,200 shares, worth US$39.9M. Across 3 filings, Carmignac Gestion increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 683,200 shares valued at US$39.9M — an increase of 52,500 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 631.20K $30.28M New
Q2 2026 630.70K $35.36M Hold
Q3 2026 683.20K $39.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 48 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$598.8M), Baillie Gifford & Co (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has Carmignac Gestion held RPRX?

Carmignac Gestion has disclosed RPRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Carmignac Gestion's current position in RPRX?

As of Q3 2026, Carmignac Gestion holds 683.20K shares of RPRX (ROYALTY PHARMA PLC), valued at $39.87M, representing 0.63% of its reported portfolio and ranking #36.

Has Carmignac Gestion been buying or selling RPRX?

In the latest 13F filing (Q3 2026), Carmignac Gestion increased its position in RPRX. The position peaked in Q3 2026 at 683.20K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, ROYAL LONDON ASSET MANAGEMENT LTD, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.